Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > (1R,2R,4S)-4-[(3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7,12-tetrahydroxy-6,11-dioxo-1-naphthacenecarboxylic acid

(1R,2R,4S)-4-[(3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7,12-tetrahydroxy-6,11-dioxo-1-naphthacenecarboxylic acid

(1R,2R,4S)-4-[(3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7,12-tetrahydroxy-6,11-dioxo-1-naphthacenecarboxylic acid structure

(1R,2R,4S)-4-[(3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7,12-tetrahydroxy-6,11-dioxo-1-naphthacenecarboxylic acid 

structure
  • CAS No:

    97583-07-8

  • Formula:

    C27H29NO11

  • Chemical Name:

    (1R,2R,4S)-4-[(3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7,12-tetrahydroxy-6,11-dioxo-1-naphthacenecarboxylic acid

  • Synonyms:

    1-Naphthacenecarboxylic acid,4-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7,12-tetrahydroxy-6,11-dioxo-,(1R,2R,4S)-;1-Naphthacenecarboxylic acid,4-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7,12-tetrahydroxy-6,11-dioxo-,[1R-(1α,2β,4β)]-;(1R,2R,4S)-4-[(3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7,12-tetrahydroxy-6,11-dioxo-1-naphthacenecarboxylic acid;Carbolbicin;D 788-1;Carborubicin;Antibiotic D 788-1;163891-88-1

  • Categories:

    Biochemical Engineering  >  Saccharides

Description

ChEBI: An anthracycline antibiotic that is 13-deoxycarminomycin substituted at position 10 by a carboxy group.


10-carboxy-13-deoxycarminomycin is an anthracycline antibiotic that is 13-deoxycarminomycin substituted at position 10 by a carboxy group. It is an aminoglycoside, an anthracycline antibiotic, a deoxy hexoside, a monosaccharide derivative, a hydroxy monocarboxylic acid and a member of p-quinones. It derives from a carminomycin. It is a tautomer of a 10-carboxy-13-deoxycarminomycin zwitterion.

(1R,2R,4S)-4-[(3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7,12-tetrahydroxy-6,11-dioxo-1-naphthacenecarboxylic acid Basic Attributes

543.525

543.52

Characteristics

217

0.2

Drug Information

10-carboxy-13-deoxocarminomycin

Computed Properties

Molecular Weight:543.5
XLogP3:0.2
Hydrogen Bond Donor Count:7
Hydrogen Bond Acceptor Count:12
Rotatable Bond Count:4
Exact Mass:543.17406074
Monoisotopic Mass:543.17406074
Topological Polar Surface Area:217
Heavy Atom Count:39
Complexity:993
Defined Atom Stereocenter Count:7
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.